Support PenkeLigand Pharmaceuticals Incorporated - Trending symbols
Latest News of Ligand Pharmaceuticals Incorporated
| Date | Title | Read |
|---|---|---|
| 2025-08-21 19:39 | Ligand Pharmaceuticals stock hits 52-week high at $157.54 | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-09-19 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | -65,390 | 59,051 | -6,339 | -32,861 | -39,200 | -10,980 | -50,180 | 61,403 | 11,223 | |
| Net Income | -51,911 | 44,739 | -7,172 | -23,916 | -31,088 | -11,363 | -42,451 | 47,298 | 4,847 | |
| Net Income from Continuing Operations | -51,911 | 44,739 | -7,172 | -23,916 | -31,088 | -11,363 | -42,451 | 47,298 | 4,847 | |
| Total Other Income Expense Net | -46,290 | 36,808 | -9,482 | -20,081 | -29,563 | 15,599 | -13,964 | 16,743 | 2,779 | |
| Accumulated Other Comprehensive Income | -944 | 127 | -817 | -93 | -910 | -25 | -935 | 2,681 | 1,746 | |
| Tax Provision | 453 | 38,221 | 38,674 | -26,752 | 11,922 | -11,041 | 881 | -3,433 | -2,552 | |
| Income Tax Expense | 453 | 38,221 | 38,674 | -26,752 | 11,922 | -11,041 | 881 | -3,433 | -2,552 | |
| Interest Expense | 332 | -331 | 1 | 1,194 | 1,195 | 841 | 2,036 | -2,037 | -1 | |
| Depreciation and Amortization | 11,813 | 11 | 11,824 | -6 | 11,818 | -3,279 | 8,539 | -51,065 | -42,526 | |
| Other Current Assets | 5,161 | -490 | 4,671 | -15 | 4,656 | 3,148 | 7,804 | -7,911 | -107 | |
| Net Interest Income | -4,270 | -14 | -4,284 | 3,629 | -655 | 515 | -140 | 399 | 259 | |
| Gross Profit | 54,082 | -693 | 53,389 | 7,100 | 60,489 | -14,796 | 45,693 | -46,162 | -469 | |
| Operating Income | 4,715 | 41,024 | 45,739 | -30,033 | 15,706 | -2,972 | 12,734 | -22,040 | -9,306 | |
| Net Debt | 403,152 | -69,001 | 334,151 | -33,605 | 300,546 | 6,606 | 307,152 | -312,003 | -4,851 | |
| EBIT | 9,760 | 1,835 | 11,595 | 26,589 | 38,184 | -18,486 | 19,698 | -22,440 | -2,742 | |
| Net Income Applicable to Common Shares | 5,761 | 12,345 | 18,106 | 12,619 | 30,725 | -17,002 | 13,723 | -18,691 | -4,968 |
Comments
How you think about this?